Navigation Links
A 'grape' future for Alzheimer's disease research
Date:11/6/2007

With National Alzheimers Awareness Month upon us, attention continues to focus on new approaches to cognitive health in an aging population. Now, research with grape polyphenols presented today at Neuroscience 2007 in San Diego shows promise for maintaining long-term cognitive health. The researchers will now focus on grape polyphenols and Alzheimers disease (AD) at the newly established Center for Research in Alternative and Complementary Medicine in Alzheimers disease research at Mount Sinai School of Medicine (MSSM).

Two recent population studies associated moderate red wine and 100 percent fruit juice consumption with lowering the risk of AD dementia (wine) or delay in AD onset (juice). Adding further weight to those studies is the research presented by Dr. Lap Ho at Neuroscience 2007, which demonstrated the potentially protective effect of Concord grape juice and Cabernet Sauvignon polyphenols to slow beta-amyloid neuropathology.

A characteristic hallmark of Alzheimers disease-type neuropathology is the accumulation of beta-amyloid peptides and their formation into plaques in the brain. Dr. Ho at MSSM found that polyphenol extracts from Cabernet Sauvignon and Concord grape juice reduced the generation and accumulation of beta-amyloid peptides in experimental models of Alzheimers disease.

This grape polyphenol research is preliminary, but very encouraging, said Dr. Giulio Pasinetti, director of the new center and principal investigator of the research program in polyphenolics at MSSM. The results show the potential protective role which non-alcoholic, polyphenol-rich Concord grape juice may play in maintaining long term cognitive health.

Previous work by Dr. Pasinettis group at MSSM reported that moderate consumption of Cabernet Sauvignon wine had reduced AD-type neuropathology and prevented cognitive decline in a transgenic mouse model , yet counseled that even moderate intake of alcohol may carry health risks, particularly with an older population.

Currently, it is estimated that five million people in the United States suffer from Alzheimers disease, with the number projected to reach 11 to 16 million by the year 2050. However, delaying the onset of Alzheimers disease by five years is estimated to potentially reduce the number of projected cases by 50 percent. Ongoing studies directed by Dr. Pasinetti at the new center will provide critical information about the functional role of selected grape-derived polyphenols in the prevention and/or attenuation of cognitive deterioration of Alzheimers disease.

Our goal is to learn which compounds are bioactively available to reach the brain and exert a benefit, says Dr. Pasinetti.


'/>"/>

Contact: Amy Coles
acoles@hunterpr.com
212-679-6600
Hunter Public Relations
Source:Eurekalert

Related medicine news :

1. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
2. New All-Natural Dietary Supplement Made from Muscadine Grape Skins Helps Inhibit Growth of Certain Cancers
3. Red wine and grape juice help defend against food-borne diseases, according to MU researchers
4. Grape Consumption Improves Antioxidant Capacity in Humans
5. Researchers study potential health benefits of natural chemicals in muscadine grape seeds
6. Grapes in Diet Decrease Risk of Hypertensive Heart Failure
7. Campaign for Americas Future Memorandum: Katrina Storm Warning
8. Shipcom Partners With DOKUMENTA for METROs Future Store Initiative
9. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
10. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
11. The Humana Foundation and Libraries for the Future Launch Health Literacy Pilot in Atlanta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: